Vaccines and delivery technologies

Vaccines and delivery technologies

All topics related to vaccine products, presentation and packaging; also includes temperature indicators such as vaccine vial monitors (VVMs) and vaccine delivery devices.

K2_MonAMUTCE_October+0000ROctAMUTC_1E42

Pfenex launched a multiproduct research program with PATH, a global health nonprofit organization, as part of an initiative to enhance vaccine production. Recently, PATH received a grant from the Bill & Melinda Gates Foundation to develop a model for enhancing the production of recombinant protein vaccines against two diseases that…

K2_MonAMUTCE_October+0000ROctAMUTC_1E41

Vials of injectable medication meant for more than one patient pose an infection risk and should no longer be used, says a leading Ontario infection control expert. “Don’t get me started on multi-dose vials. We should not be using multi-dose vials in this day and age,” said Dr. Allison McGeer,…

K2_TuePMUTCE_September+0000RSepPMUTC_2E40

U.S. hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said. Waste management companies are refusing to haul away the soiled sheets and virus-spattered protective gear…

K2_TueAMUTCE_September+0000RSepAMUTC_2E40

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability. “The goal of this research is to identify novel adjuvant candidates…

K2_TueAMUTCE_September+0000RSepAMUTC_2E39

Those melt-on-your-tongue mouthwash strips on sale at the grocery checkout don’t just zap your foul-smelling pizza breath — it turns out they have spawned potentially life-saving public-health innovations, too. Scientists with the Biointerfaces Institute at McMaster University are using a compound found in the breath-freshening film to create what they…

K2_WedAMUTCE_September+0000RSepAMUTC_3E38

At the TEDMED conference in Washington, DC, Dr. Marie-Paule Kieny, assistant director general of the World Health Organization (WHO), revealed that the organization will announce its third-ever global health initiative and policy in October. The initiative this time is around needle safety. The announcement came during a TEDMED presentation by…

K2_WedAMUTCE_September+0000RSepAMUTC_3E38

In a step towards finding alternatives to administering drugs using needles and syringes, the World Health Organization (WHO) on Tuesday announced the launch of clinical trials for polio vaccine using a nanopatch — a chip comprising thousands of microscopic bumps. While the traditional needle and syringe delivers the vaccine to…

K2_FriAMUTCE_September+0000RSepAMUTC_5E37

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the US Patent and Trademark Office (US PTO) granted patent 8,808,710 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine…
Page 5 of 6